Big Health is using an upcoming educational webinar to push deeper adoption of its SleepioRx prescription digital therapeutic for insomnia among healthcare providers. The company is positioning digital CBT-I as a scalable way to expand access to evidence-based insomnia care while clarifying how SleepioRx fits into everyday clinical workflows.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Scheduled for May 15, 2026, the 30-minute session will be led by senior clinical leaders, including Big Health’s Chief Medical Officer and VP of Clinical Affairs. They plan to highlight the clinical evidence supporting SleepioRx, share real-world patient case studies, and explain specific clinical use cases to build physician confidence.
The webinar will also tackle practical questions around cost, coverage, and billing, as well as alternative referral and contracting models such as direct contracts and embedded referrals. By addressing reimbursement hurdles and operational integration, Big Health aims to reduce adoption friction and make SleepioRx easier for providers to incorporate into routine care.
Strategically, this provider-focused education push signals a shift toward deeper penetration in clinical settings rather than relying solely on employer or consumer channels. If providers respond positively, the initiative could support higher prescription volumes, more stable recurring revenue streams, and stronger payer relationships in the digital behavioral health market.
Overall, the week’s developments underscore Big Health’s emphasis on clinical validation and workflow fit as levers to scale SleepioRx and solidify its competitive position in digital therapeutics for insomnia.